Prevention and treatment of chemotherapy-induced nausea and vomiting - European Medical Journal

Prevention and treatment of chemotherapy-induced nausea and vomiting

Oncology

At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Richard Berman, MBBS, MRCGP, FRCP, of The Christie NHS Foundation Trust, Manchester, UK, discusses the recent progress, including the development of 5-HT3 and neurokinin-1 receptor antagonists as potential pharmacologic treatment options, in the management of chemotherapy-induced nausea and vomiting.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given